4.7 Article

Cigarette smoking-associated isoform switching and 3′ UTR lengthening via alternative polyadenylation

Journal

GENOMICS
Volume 113, Issue 6, Pages 4184-4195

Publisher

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.ygeno.2021.11.004

Keywords

Transcriptomics; Smoking; Alternative polyadenylation

Funding

  1. NHLBI
  2. NIGMS
  3. FDA Center for Tobacco Products (CTP)
  4. [R01 HL124233]
  5. [R01 HL147326]
  6. [R01 HL111527]
  7. [U01 HL089897]
  8. [U01 HL089856]
  9. [R01HL125583]
  10. [R01HL130512]
  11. [R01 GM101237]
  12. [R01 HL11152]
  13. [K25HL140186]
  14. [K08HL141601]

Ask authors/readers for more resources

Cigarette smoking induces significant transcriptomic and systemic inflammatory responses, affecting gene expression, alternative isoform regulation, and exon usage. Lengthening of 3' UTRs associated with smoking suggests potential biomarkers and therapeutic targets for smoking-related diseases, emphasizing the importance of further research in this area.
Cigarette smoking induces a profound transcriptomic and systemic inflammatory response. Previous studies have focused on gene level differential expression of smoking, but the genome-wide effects of smoking on alternative isoform regulation have not yet been described. We conducted RNA sequencing in whole-blood samples of 454 current and 767 former smokers in the COPDGene Study, and we analyzed the effects of smoking on differential usage of isoforms and exons. At 10% FDR, we detected 3167 differentially expressed genes, 945 differentially used isoforms and 160 differentially used exons. Isoform switch analysis revealed widespread 3 ' UTR lengthening associated with cigarette smoking. The lengthening of these 3 ' UTRs was consistent with alternative usage of distal polyadenylation sites, and these extended 3 ' UTR regions were significantly enriched with functional sequence elements including microRNA and RNA-protein binding sites. These findings warrant further studies on alternative polyadenylation events as potential biomarkers and novel therapeutic targets for smoking-related diseases.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available